CLEANING VALIDATION FOR ESTIMATION OF ACTIVE INGREDIENTS’ RESIDUES OF VICAZID UNCOATED TABLETS (PYRANTEL 100 MG/MEBENDAZOLE 150 MG) ON SURFACES OF PHARMACEUTICAL MANUFACTURING EQUIPMENT USING SWAB SAMPLING AND HPLC METHOD
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2015, Vol 7, Issue 6
Abstract
Objective: The validation of HPLC methods for residual estimation of pyrantel and mebendazole in swab samples from equipment surfaces after manufacturing of Vicazid uncoated tablets and the demonstration of the efficiency of the cleaning procedure.Methods: For pyrantel residues: Column-Luna Silica 250×4.6 mm, 5 µm; Mobile phase-a mixture of acetonitrile, acetic acid, diethyl amine and water (92.8:3:1.2:3); The flow rate-1.0 ml/min; The detector wavelength-288 nm; The injection volume-20 μl. For mebendazole residues: Column-Luna C18(2) 150×4.6 mm, 5 µm; Mobile phase-a mixture of methanol and 0.05 M monobasic potassium phosphate solution (60:40) pH 5.5; The flow rate-1.5 ml/min; The detector wavelength-247 nm; The injection volume-15 μl.Results: The calibration curve is linear (the correlation coefficient>0.999) over a concentration range 0.04-80μg/ml (pyrantel pamoate) and 0.005-50μg/ml (mebendazole); The limit of detection and limit of quantitation-0.04 (pyrantel pamoate)/0.005 (mebendazole) and 0.08 (pyrantel pamoate)/0.0125μg/ml (mebendazole), respectively; The mean recovery is>90 %; No interference from swab solution was observed and samples were stable for 24 h. The determined amounts (varying 0.02–9.74 µg pyrantel residues and 0.09–61.19 µg mebendazole) are well below the calculated limit of contamination.Conclusion: The HPLC methods with appropriate swab wipe procedure were validated and the obtained results confirm that the cleaning procedures used are able to remove residues of both active ingredients from equipment surfaces.Â
Authors and Affiliations
Imeda Rubashvili, Natela Karukhnishvili, Khatuna Loria, Nino Dvali
Keywords
Related Articles
- EP ID EP578680
- DOI -
- Views 64
- Downloads 0
RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ASPIRIN, RAMIPRIL, HYDROCHLOROTHIAZIDE, SIMVASTATIN AND ATENOLOL FROM PHARMACEUTICAL DOSAGE FORM
Objective: The present study was designed with an objective of a simple, fast, precise, selective and accurate RP-HPLC method was developed and validated for the simultaneous determination of Aspirin, Ramipril, Hydrochlo...
IDENTIFICATION OF POTENTIAL NOVEL EGFR INHIBITORS USING A COMBINATION OF PHARMACOPHORE AND DOCKING METHODS
Objective: Identifying new inhibitors of Epidermal Growth Factor Receptor (EGFR) by virtual screening using a pharmacophore model followed by docking. Methods: A pharmacophore model was developed using a dataset of 77 ch...
HEALTH-RELATED QUALITY OF LIFE IN EARLY BREAST CANCER PATIENTS WITH HORMONE RESPONSIVE
Objective: The management of early breast cancer (EBC) is performed with a series of treatments consisting of surgery and systemic therapy, along with long-term endocrine therapy for hormone responsive. The treatment gen...
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF HYDROCHLOROTHIAZIDE, AMLODIPINE BESYLATE AND TELMISARTAN HYDROCHLORIDE IN MULTICOMPONENT TABLET DOSAGE FORM AND IN BIORELEVANT MEDIA (FASSIF) BY RP-HPLC TECHNIQUES
Objective: A simple, rapid, and precise reverse phase high performance liquid chromatographic (RP-HPLC) method for simultaneous analysis of Hydrochlorothiazide (HTZ), Amlodipine besylate (AML) and Telmisartan hydrochlori...
NEWER OPHTHALMIC IN SITU GEL OF MOXIFLOXACIN HYDROCHLORIDE: OPTIMIZATION USING BOX BEHNKEN STATISTICAL DESIGN
Objective: The present research work aims at describing the formulation and evaluation of the ocular delivery system of moxifloxacin hydrochloride (MH) based on the concept of ion sensitive in situ gelations. Methods: I...